US EditionPublished • loading... • Updated
Sequence LifeScience, Inc. Announces First Patient Enrolled in Groundbreaking Clinical Trial for Diabetic Foot Ulcers
Summary by WAOW
17 Articles
17 Articles
The Norfolk Daily News+16 Reposted by 16 other sources
Sequence LifeScience, Inc. Announces First Patient Enrolled in Groundbreaking Clinical Trial for Diabetic Foot Ulcers
SAN ANTONIO, Oct. 8, 2025 /PRNewswire/ -- Sequence LifeScience Inc., a leader in allograft tissue processing, today announced a major milestone in its clinical development program: the first patient has been enrolled and treatment initiated in the company's innovative multicenter,…
Coverage Details
Total News Sources17
Leaning Left0Leaning Right0Center8Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
